# Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression

> **NCT01387022** · NA · COMPLETED · sponsor: **Centre for the AIDS Programme of Research in South Africa** · enrollment: 59 (actual)

## Conditions studied

- Antiretroviral Treatment Outcomes

## Interventions

- **DRUG:** Tenofovir, lamivudine and efavirenz

## Key facts

- **NCT ID:** NCT01387022
- **Lead sponsor:** Centre for the AIDS Programme of Research in South Africa
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01387022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01387022, "Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01387022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*